News
A study finds that adjunctive use of GLP-1 receptor agonists before and after undergoing bariatric surgery produces greater ...
Table of Contents The Real Story Behind Your Changing Body Making Every Bite Count When You’re Eating Less Your Brain […] The ...
For patients with idiopathic intracranial hypertension (IIH), glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment ...
Popular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...
2h
HealthDay on MSNDementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DMFor older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1 receptor agonists (GLP-1 RAs) versus dipeptidyl ...
More data, this time from a large observational study, are bolstering the idea that glucagon-like peptide-1 (GLP-1) receptor ...
Explore more
6h
News-Medical.Net on MSNMuscle loss from GLP-1 drugs could undermine long-term healthPopular GLP-1 drugs help many people drop tremendous amounts of weight, but the drugs fail to provide a key improvement in ...
GLP-1 drugs came out in 2005 as a Type 2 diabetes treatment. But in recent years their popularity for weight loss -- and the ...
Studies presented at the Society of Neurointerventional Surgery’s show links between GLP-1s and the prevention of strokes and ...
Wraparound care for patients taking GLP-1 agonists must include assessment of nutritional status to identify the risk of malnutrition, writes Ellen Fallows Food insecurity is increasing, particularly ...
National Weight Loss Doctor Scott Masey joined Bloom Health Club to explain what GLP-1 drugs really do, and what most people aren’t being told. “These meds don’t just help with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results